Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Aspirin / Dipyridamole

Known as: Aspirin Dipyridamole Drug Combination, Combination, Aspirin-Dipyridamole Drug, ASPIRIN/DIPYRIDAMOLE 
A drug combination of aspirin and dipyridamole that functions as a PLATELET AGGREGATION INHIBITOR, used to prevent THROMBOSIS and STROKE in TRANSIENT… Expand
National Institutes of Health

Related topics

Related topics

14 relations
12 HR Aspirin 25 MG / Dipyridamole 200 MG Extended Release Oral CapsuleAspirinDipyridamoleIn Blood
Expand

Narrower (3)

AggrenoxAsasantinAsasantin Retard

Broader (1)

Platelet Aggregation Inhibitors

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2006
Highly Cited
2006
Use of single and combined antithrombotic therapy and risk of serious upper gastrointestinal bleeding: population based case-control study
Abstract Objectives To assess the risk of serious upper gastrointestinal bleeding associated with the newer antithrombotic agents… Expand
Highly Cited
2005
Highly Cited
2005
Dipyridamole Selectively Inhibits Inflammatory Gene Expression in Platelet–Monocyte Aggregates
Background—Drugs that simultaneously decrease platelet function and inflammation may improve the treatment of cardiovascular… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
1994
Highly Cited
1994
Anti-platelet therapy in graft thrombosis: results of a prospective, randomized, double-blind study.
Hemodialysis (HD) vascular access thrombosis remains a major cause of morbidity, accounting for 17.4% of all HD patient hospital… Expand
Highly Cited
1987
Highly Cited
1987
Early and late results of intracoronary arterial stenting after coronary angioplasty in dogs.
Intimal dissection with acute closure represents the major complication associated with percutaneous transluminal coronary… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Review
1986
Review
1986
Role of platelets and platelet inhibitors in aortocoronary artery vein-graft disease.
To study the prevention of occlusion of aortocoronary-artery bypass grafts, we conducted a prospective, randomized, double-blind… Expand
  • figure 1
  • table 1
  • table 3
  • table 2
  • figure 2
Highly Cited
1984
Highly Cited
1984
Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations.
To study the prevention of occlusion of aortocoronary-artery bypass grafts, we concluded a prospective, randomized, double-blind… Expand
Highly Cited
1984
Highly Cited
1984
Membranoproliferative glomerulonephritis. A prospective clinical trial of platelet-inhibitor therapy.
Forty patients with Type I membranoproliferative glomerulonephritis were treated for one year with dipyridamole, 225 mg per day… Expand
Highly Cited
1982
Highly Cited
1982
A platelet-inhibitor-drug trial in coronary-artery bypass operations: benefit of perioperative dipyridamole and aspirin therapy on early postoperative vein-graft patency.
To prevent occlusion of aortocoronary-artery-bypass grafts, we conducted a prospective, randomized-double-blind trial comparing… Expand
Highly Cited
1982
Highly Cited
1982
Elevated levels of circulating platelet aggregates and beta-thromboglobulin in scleroderma.
Levels of circulating platelet aggregates and plasma beta-thromboglobulin reflect the degree of platelet activation in vascular… Expand
Highly Cited
1979
Highly Cited
1979
Reduction of intimal thickening in canine coronary bypass vein grafts with dipyridamole and aspirin.
The potential benefit of platelet inhibitor drugs on coronary arterial bypass vein grafts was assessed in dogs with magnification… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE